Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker
Authors:
- Verónica M. Borgonio-CuadraVBVerónica M. Borgonio-Cuadra
- Aranza Meza-DorantesAMAranza Meza-Dorantes
- José Manuel Rodríguez-PérezJRJosé Manuel Rodríguez-Pérez
- Ian A. García-AguirreIGIan A. García-Aguirre
- Nadia Mireya Murillo-MeloNMNadia Mireya Murillo-Melo
- Nonanzit Pérez-HernándezNPNonanzit Pérez-Hernández
- Oscar Hernández-HernándezOscar Hernández-Hernández
- Marcela Hernández-OrtegaMHMarcela Hernández-Ortega
- Zazil Herrera-CarrilloZHZazil Herrera-Carrillo
- Bulmaro CisnerosBCBulmaro Cisneros
- Jonathan J. MagañaJMJonathan J. Magaña
Open Access
- 9 January 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 683
Abstract
Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disease characterized by cerebellar ataxia and retinal degeneration, caused by an abnormal expansion of CAG repeats at the ATXN7 gene. Disease onset and progression vary among patients, underscoring the need for novel tools to improve disease monitoring. Circulating miRNAs represent a promising prognostic tool, due to their minimally invasive sampling and high stability. The aim of this study was to assess the expression of twelve circulating miRNAs associated with neurodegeneration in plasma samples from SCA7 patients and in an inducible SCA7 glial cell model. A comparison of SCA7 patients and controls revealed that nine miRNAs exhibited significantly higher expression. Furthermore, comparison of patients with different SCA7 phenotypes to controls revealed that most miRNAs were overexpressed in plasma from early-onset patients corresponding to the clinically more severe phenotype. Regarding the cell model, we identified three miRNAs that were dysregulated; however, only hsa-miR-342-5p displayed a pattern consistent with that observed in the plasma of patient. Our findings indicate that hsa-miR-342-5p is differentially expressed in the plasma of patients and the SCA7 cellular model, implying that it can serve as a biomarker and facilitate the identification of novel processes involved in SCA7.Keywords
Funding Information
- Consejo Nacional de Ciencia y Tecnología, Paraguay (SEP-2015-258043)
This publication has 74 references indexed in Scilit:
- 3D Bioprinting of Neural TissuesAdvanced Healthcare Materials, 2020
- The microRNA-17 ~ 92 Family as a Key Regulator of Neurogenesis and Potential Regenerative Therapeutics of Neurological DisordersStem Cell Reviews and Reports, 2020
- Shear Wave Velocity Measurements of the Median Nerve in Patients on Chronic HemodialysisJournal of Ultrasound in Medicine, 2020
- Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7Molecular Neurobiology, 2019
- An overview of microRNAs: Biology, functions, therapeutics, and analysis methodsJournal of Cellular Physiology, 2018
- Spinocerebellar ataxia: an updateJournal of Neurology, 2018
- A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7neurogenetics, 2014
- The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in miceActa Neuropathologica, 2014
- Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegenerationThe Cerebellum, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001